Clinical trials

Condition   Drug Name  
Study Pimecrolimus in atopic dermatitis
Design Randomized; Double-blind; Multicenter
Patients 200
Treatment Regimen Pimecrolimus 1% cream top. b.i.d. x 6 wks --> PRN x 6 wks; Placebo x 6 wks --> Pimecrolimus 1% cream top. PRN x 6 wks
Conclusions Pimecrolimus cream was well tolerated and effectively reduced signs and symptoms of atopic dermatitis
Reference(s) A randomized, controlled trial of pimecrolimus cream 1% in children with head and neck atopic dermatitis and intolerant of, or dependent on topical corticosteroids
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1565.
Author and Affiliation Hoeger, P., Lee, K.-H., Jautova, J., Wohlrab, J., Guettner, A., Mizutani, G.